1. Home
  2. Author
  3. Durrleman S

Durrleman S

References (2)

Title : Long-term effect of discontinuing anticholinesterase treatment on cognitive decline and mortality in Alzheimer's disease in France: a quasi-experiment and target trial emulation study - Lecerf_2026_Lancet.Reg.Health.Eur_62_101607
Author(s) : Lecerf S , Guinebretiere O , Bentegeac R , Gauthier V , Aymes E , Mekkaoui C , Dumurgier J , Amouyel P , Durrleman S , Nedelec T , Lebouvier T
Ref : Lancet Reg Health Eur , 62 :101607 , 2026
Abstract :
PubMedSearch : Lecerf_2026_Lancet.Reg.Health.Eur_62_101607
PubMedID: 41732331

Title : Revolution of Alzheimer Precision Neurology. Passageway of Systems Biology and Neurophysiology - Hampel_2018_J.Alzheimers.Dis_64_S47
Author(s) : Hampel H , Toschi N , Babiloni C , Baldacci F , Black KL , Bokde ALW , Bun RS , Cacciola F , Cavedo E , Chiesa PA , Colliot O , Coman CM , Dubois B , Duggento A , Durrleman S , Ferretti MT , George N , Genthon R , Habert MO , Herholz K , Koronyo Y , Koronyo-Hamaoui M , Lamari F , Langevin T , Lehericy S , Lorenceau J , Neri C , Nistico R , Nyasse-Messene F , Ritchie C , Rossi S , Santarnecchi E , Sporns O , Verdooner SR , Vergallo A , Villain N , Younesi E , Garaci F , Lista S
Ref : J Alzheimers Dis , 64 :S47 , 2018
Abstract :
PubMedSearch : Hampel_2018_J.Alzheimers.Dis_64_S47
PubMedID: 29562524